moxidectin anthelmintic drug used animals prevent control parasitic worms helminths heartworm intestinal worms dogs cats horses cattle sheep moxidectin kills common internal external parasites selectively binding parasites glutamategated chloride ion channels channels vital function invertebrate nerve muscle cells moxidectin binds channels disrupts neurotransmission resulting paralysis death parasite moxidectin approved onchocerciasis riverblindness people age united states based two need additional trials longterm followup assess whether moxidectin safe effective treatment nematode infection children women childbearing moxidectin predicted helpful achieve elimination goals nematodes develop crossresistance moxidectin similar parasiticides ivermectin doramectin moxidectin evaluated treatment eradicate scabies humans especially resistant studies moxidectin show side effects vary animal may affected products formulation application method dosagecitation needed overdose moxidectin enhances effect gammaaminobutyric acid gaba central nervous horses overdose may lead depression drooping lower lip tremor lack coordination moving ataxia decreased rate breathing respiratory rate stupor dog licks moxidectin skin applied spoton topical treatment effect overdose may cause vomiting salivation neurological signs ataxia tremor collie dogs tolerate moxidectin individuals sensitive upon ingestion experience vomiting salivation transient neurological moxidectin lipophilic causes high volume moxidectin concentrates animals adipose tissue released two months following goats oral bioavailability moxidectin times lower halflife times shorter moxidectin macrocyclic lactone milbemycin semisynthetic derivative nemadectin fermentation product bacterium streptomyces cyanogriseus subsp late american cyanamid company agronomist discovered streptomyces bacteria moxidectin derived soil sample australia two companies filed patents moxidectin glaxo group american cyanamid patents transferred american first moxidectin product sold human use moxidectin approved united states food drug administration june treatment onchocerciasis adults adolescents aged older first human approval worldwide license holder nonprofit biopharmaceutical company medicines development global httpsenwikipediaorgwikimoxidectin